| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.6 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.12 | 0.6 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.13 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |